Literature DB >> 9606099

Gastrin is the most important factor in ECL tumorigenesis.

H L Waldum, A K Sandvik, J R Idle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9606099     DOI： 10.1016/s0016-5085(98)70346-4

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  9 in total

1.  Multifocal gastric carcinoid tumor in a patient with pernicious anemia receiving lansoprazole.

Authors:  Tan Attila; Raj Santharam; Dennis Blom; Richard Komorowski; Timothy R Koch
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

Review 2.  Physiological and clinical significance of enterochromaffin-like cell activation in the regulation of gastric acid secretion.

Authors:  Guanglin Cui; Helge L Waldum
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

3.  Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study.

Authors:  Davide Campana; Davide Ravizza; Piero Ferolla; Antongiulio Faggiano; Franco Grimaldi; Manuela Albertelli; Debora Berretti; Danilo Castellani; Giulia Cacciari; Nicola Fazio; Annamaria Colao; Diego Ferone; Paola Tomassetti
Journal:  Endocrine       Date:  2015-03-27       Impact factor: 3.633

4.  Management of gastric carcinoids (neuroendocrine neoplasms).

Authors:  Mark Kidd; Bjorn I Gustafsson
Journal:  Curr Gastroenterol Rep       Date:  2012-12

5.  Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study.

Authors:  Davide Campana; Davide Ravizza; Piero Ferolla; Antongiulio Faggiano; Franco Grimaldi; Manuela Albertelli; Claudio Ricci; Donatella Santini; Nicole Brighi; Nicola Fazio; Annamaria Colao; Diego Ferone; Paola Tomassetti
Journal:  Endocrine       Date:  2016-09-03       Impact factor: 3.633

6.  A clinical perspective on gastric neuroendocrine neoplasia.

Authors:  Ben Lawrence; Mark Kidd; Bernhard Svejda; Irvin Modlin
Journal:  Curr Gastroenterol Rep       Date:  2011-02

7.  Chromogranin A in gastric neuroendocrine tumours: an immunohistochemical and biochemical study with region-specific antibodies.

Authors:  Andreas Tartaglia; Guida M Portela-Gomes; Kjell Oberg; Paolo Vezzadini; Maria P Foschini; Mats Stridsberg
Journal:  Virchows Arch       Date:  2006-01-12       Impact factor: 4.064

8.  Proton pump inhibitors on pancreatic cancer risk and survival.

Authors:  Malcolm D Kearns; Ben Boursi; Yu-Xiao Yang
Journal:  Cancer Epidemiol       Date:  2017-01-02       Impact factor: 2.984

9.  Association between proton pump inhibitors after percutaneous coronary intervention and risk of gastric cancer.

Authors:  Andrew Kei-Yan Ng; Pauline Yeung Ng; April Ip; Ka-Shing Cheung; Chung-Wah Siu
Journal:  BMJ Open Gastroenterol       Date:  2021-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.